Last updated: July 05, 2026

Application No. 18/537,704

ENDOSCOPIC SUBMUCOSAL INJECTION MATERIAL

Non-Final OA

Filed

Dec 12, 2023

Priority

Jun 16, 2021 — JP 2021-100417 +2 more

Examiner

BERRY, LAYLA D

Art Unit

1693

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Fujifilm Corporation

OA Round

1 (Non-Final)

Interview Optional

— +8.7% interview lift. Interview lift (+8.7%) is below the 15.0% threshold. A written response is recommended.

Based on 1439 resolved cases, 2023–2026

Examiner Intelligence

BERRY, LAYLA D View full profile →

Grants 66% — above average

Career Allowance Rate

948 granted / 1439 resolved

+5.9% vs TC avg

Moderate +9% lift

Without

With

+8.7%

Interview Lift

resolved cases with interview

Typical timeline

2y 9m

Avg Prosecution

34 currently pending

Career history

1479

Total Applications

across all art units

Statute-Specific Performance

§101

1.3%

-38.7% vs TC avg

§103

50.7%

+10.7% vs TC avg

§102

10.6%

-29.4% vs TC avg

§112

7.0%

-33.0% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1439 resolved cases

Prosecution Timeline

Dec 12, 2023

Application Filed

Apr 01, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

19/312,906

Patent 12667587

HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS

10m to grant Granted Jun 30, 2026

17/788,906

Patent 12662504

HIGH-SOLUBILITY REBAUDIOSIDE D COMPLEX

4y 0m to grant Granted Jun 23, 2026

18/020,119

Patent 12655173

HYBRID AMIDE DERIVATIVES OF AMPHOTERICIN B

3y 4m to grant Granted Jun 16, 2026

17/916,064

Patent 12649761

SYNTHESIS OF OLIGONUCLEOTIDES AND RELATED COMPOUNDS

3y 2m to grant Granted Jun 09, 2026

18/646,230

Patent 12649760

FUNCTIONALIZED N-ACETYLGALACTOSAMINE ANALOGS

2y 1m to grant Granted Jun 09, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

66%

Grant Probability

75%

With Interview (+8.7%)

2y 9m (~2m remaining)

Median Time to Grant

Low

PTA Risk

Based on 1439 resolved cases by this examiner. Grant probability derived from career allowance rate.